🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will evaluate the efficacy and safety of trastuzumab deruxtecan ...
Status
Active Not Recruiting
Location
Instituto Medico Especializado Alexander Fleming
Start Date
2021-05-21
Trial ID
NCT04704934
Treatments Being Tested
This study is being conducted to test the safety and efficacy of ramuciruma...
Status
Terminated
Location
Childrens Hospital of Alabama
Start Date
2020-03-04
Trial ID
NCT04145700
Treatments Being Tested
This is a study to compare the antitumor activity of ramucirumab (IMC-1121B...
Status
Completed
Location
ImClone Investigational Site
Start Date
2011-11
Trial ID
NCT01427933
Treatments Being Tested
The purpose of this study is to determine whether IMC-A12 or IMC-1121B (ram...
Status
Completed
Location
ImClone Investigational Site
Start Date
2008-08
Trial ID
NCT00683475
Treatments Being Tested
The purpose of this study is to evaluate the effects of ramucirumab in comb...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2012-12
Trial ID
NCT01703091
Treatments Being Tested
The main purpose of this study is to establish the safety and the recommend...
Status
Active Not Recruiting
Location
HonorHealth Research Institute
Start Date
2019-04-26
Trial ID
NCT03872947
The purpose of this study is to determine whether nab-Paclitaxel (Abraxane®...
Status
Completed
Location
Rocky Mountain Cancer Centers
Start Date
2015-05-05
Trial ID
NCT02317991
Treatments Being Tested
The purpose of this study is to assess the effect of concomitant ramuciruma...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician
Start Date
2012-10
Trial ID
NCT01634555
Treatments Being Tested
This is a Phase 3 multicenter, randomized study evaluating the safety and e...
Status
Completed
Location
ImClone Investigational Site
Start Date
2010-10
Trial ID
NCT01140347
Treatments Being Tested
This clinical trial consists of two parts: phase 2 and phase 3. The goal o...
Status
Not Yet Recruiting
Location
Hematology Oncology Associates of the Treasure Coast
Start Date
2026-08-28
Trial ID
NCT07718737
Treatments Being Tested